- Tytuł:
- First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology October 2023 24(10):1073-1082
Czasopismo naukowe